Swiss stocks - Factors to watch on Oct 15

ZURICH Oct 15 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Thursday:

ROCHE (ROG.VX)

Roche's third-quarter sales rose 14 percent to 12.4 billion Swiss francs ($12.2 billion), helped by its cancer drugs and beating expectations, and it upped its forecast for flu medicine Tamiflu.

For related news click on [ROG.VX]

UBS (UBSN.VX)

Some 7,500 wealthy Americans turned over information about hidden overseas assets, including some valued at more than $100 million, ahead of a tax amnesty programme's Thursday deadline, the top U.S. tax collector said.

For related news click on [UBSN.VX]

ECONOMY [M-CH]

ZEW investor sentiment data for October is due at 0900 GMT.

COMPANY STATEMENTS [CNR-CH]

* Walter Meier (WMN.S) plans a share buyback for capital reduction [WMN.S]

* Credit Suisse (CSGN.VX) is pleased to announce the appointment of Doug Cliggott as the U.S. Equity Strategist, effective immediately.[CSGN.VX]

EQUITY RESEARCH [CH-RCH]

FOR COMPANIES TRADING EX-DIVIDEND, PLEASE CLICK ON:

.EX.S for all Swiss stocks

.EXSMI.S for blue chips

.EXNSMI.S for other stocks